BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 27870881)

  • 1. Associations between XRCC1 Gene Polymorphisms and Coronary Artery Disease: A Meta-Analysis.
    Ma WQ; Han XQ; Wang X; Wang Y; Zhu Y; Liu NF
    PLoS One; 2016; 11(11):e0166961. PubMed ID: 27870881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of X-ray repair cross-complementing group 1 Arg194Trp, Arg399Gln and Arg280His polymorphisms with head and neck cancer susceptibility: a meta-analysis.
    Wu W; Liu L; Yin Z; Guan P; Li X; Zhou B
    PLoS One; 2014; 9(1):e86798. PubMed ID: 24497981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and cervical cancer risk: a huge systematic review and meta-analysis.
    Li Y; Liu F; Tan SQ; Wang Y; Li SW
    PLoS One; 2012; 7(9):e44441. PubMed ID: 22984511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. XRCC1 Arg399Gln and Arg194Trp polymorphisms in prostate cancer risk: a meta-analysis.
    Wei B; Zhou Y; Xu Z; Ruan J; Zhu M; Jin K; Zhou D; Hu Q; Wang Q; Wang Z; Yan Z
    Prostate Cancer Prostatic Dis; 2011 Sep; 14(3):225-31. PubMed ID: 21647176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of XRCC1 Arg399Gln and Arg194Trp polymorphisms with susceptibility to multiple autoimmune diseases: a meta-analysis.
    Peng M; Zhou X; Ding X; Wei L; Zhao Y; Zhu T; Shi X; Qin D
    Rheumatol Int; 2017 Mar; 37(3):435-444. PubMed ID: 27812739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. XRCC1 Arg399Gln and Arg194Trp polymorphisms in childhood acute lymphoblastic leukemia risk: a meta-analysis.
    Wang R; Hu X; Zhou Y; Feng Q; Su L; Long J; Wei B
    Leuk Lymphoma; 2013 Jan; 54(1):153-9. PubMed ID: 22712837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The XRCC1 Arg194Trp polymorphism was associated with the risk of head and neck squamous cell carcinoma development: Results from a systematic review and meta-analysis.
    Mohtasham N; Najafi-Ghobadi K; Abbaszadeh H
    Cancer Rep (Hoboken); 2023 Mar; 6(3):e1776. PubMed ID: 36573562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative assessment of the association between XRCC1 Arg399Gln and Arg194Trp polymorphisms and risk of cutaneous melanoma.
    Jiang H; Xu W; Zhang F; Wei L; Wang Y; Wang Y; Liu C
    Melanoma Res; 2016 Jun; 26(3):290-9. PubMed ID: 26967970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The polymorphism of XRCC1 and coronary artery disease risk: a meta-analysis.
    Guo SJ; Zhou YT; Liu WY; Zuo QN; Li XH
    Eur Rev Med Pharmacol Sci; 2017 Apr; 21(7):1559-1567. PubMed ID: 28429350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A meta-analysis of XRCC1 single nucleotide polymorphism and susceptibility to gynecological malignancies.
    Zhang XQ; Li L
    Medicine (Baltimore); 2021 Dec; 100(50):e28030. PubMed ID: 34918657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. XRCC1 Arg194Trp and Arg280His polymorphisms increase bladder cancer risk in Asian population: evidence from a meta-analysis.
    Fang Z; Chen F; Wang X; Yi S; Chen W; Ye G
    PLoS One; 2013; 8(5):e64001. PubMed ID: 23704969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. XRCC1 gene polymorphisms and glioma risk in Chinese population: a meta-analysis.
    He LW; Shi R; Jiang L; Zeng Y; Ma WL; Zhou JY
    PLoS One; 2014; 9(11):e111981. PubMed ID: 25375625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Association Between the XRCC1 Arg399Gln Polymorphism and the Risk of Head and Neck Cancer: An Updated Meta-Analysis Including 14586 Subjects.
    Xia S; Wu S; Wang M
    Technol Cancer Res Treat; 2021; 20():15330338211033060. PubMed ID: 34278875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. XRCC1 Arg399Gln, Arg194Trp, and Arg280His polymorphisms in esophageal cancer risk: a meta-analysis.
    Li S; Deng Y; You JP; Chen ZP; Peng QL; Huang XM; Lu QH; Huang XL; Zhao JM; Qin X
    Dig Dis Sci; 2013 Jul; 58(7):1880-90. PubMed ID: 23543084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of associations between XRCC1 gene polymorphisms and susceptibility to systemic lupus erythematosus and rheumatoid arthritis.
    Zhang MY; Yang XK; Lv TT; Wu J; Xu SZ; Wang JB; Pan HF; Ye DQ
    Int J Rheum Dis; 2018 Jan; 21(1):179-185. PubMed ID: 28198159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The XRCC1 Arg194Trp and Arg280His polymorphisms in head and neck cancer susceptibility: a meta-analysis.
    Zhou X; Gu L; Zeng Y; Wei L; Ying M; Wang N; Su C; Wang Y; Liu C
    Tumour Biol; 2014 Nov; 35(11):10665-76. PubMed ID: 25062722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between X-ray cross-complementing group 1 polymorphisms and the onset risk of glioma: A meta-analysis.
    Gu X; Sun H; Chang L; Sun R; Yang H; Zhang X; Cong X
    Neural Regen Res; 2013 Sep; 8(26):2468-77. PubMed ID: 25206557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA repair gene XRCC1 polymorphisms and head and neck cancer risk: an updated meta-analysis including 16344 subjects.
    Lou Y; Peng WJ; Cao DS; Xie J; Li HH; Jiang ZX
    PLoS One; 2013; 8(9):e74059. PubMed ID: 24086310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. X-ray repair cross-complementing group 1(XRCC1) genetic polymorphisms and thyroid carcinoma risk: a meta-analysis.
    Qian K; Liu KJ; Xu F; Chen XY; Chen GN; Yi WJ; Zhou EX; Tang ZH
    Asian Pac J Cancer Prev; 2012; 13(12):6385-90. PubMed ID: 23464463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations between three XRCC1 polymorphisms and glioma risk: a meta-analysis.
    Zhang H; Liu H; Knauss JL
    Tumour Biol; 2013 Oct; 34(5):3003-13. PubMed ID: 23712607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.